Navigation Links
Hutchinson Center president elected to American Academy of Art and Sciences
Date:4/17/2012

SEATTLE Larry Corey, M.D., president and director of Fred Hutchinson Cancer Research Center, has been elected to membership in the American Academy of Arts and Sciences, one of the nation's oldest and most prestigious honorary societies and independent policy-research centers.

"I'm extremely honored to be in the same company as so many highly-regarded people in the fields of science, medicine and the arts," Corey said. "I'm also very proud to join the six other Hutchinson Center scientists who preceded me as members of the academy."

Corey has led the Hutchinson Center since January 2011 and has held other leadership positions there since 1996, first as head of infectious disease sciences in the Clinical Research Division and later as senior vice president and co-director of the Center's Vaccine and Infectious Disease Division.

He is the Hutchinson Center's second president to be elected to the Academy. Yeast geneticist Lee Hartwell, Ph.D., a 2001 Nobel laureate, was elected in 1998. He led the Center from 1997 until 2010.

Corey is among 220 leaders in the sciences, social sciences, humanities, arts, business and public affairs who have been elected to the American Academy of Arts and Sciences 2012 class of fellows. This year's class includes winners of the National Medal of Science, the Lasker Award, the Pulitzer Prize, MacArthur and Guggenheim fellowships, the Kennedy Center Honors, as well as Grammy, Emmy, Academy and Tony awards.

The new class will be inducted at a ceremony Oct. 6 at the Academy's headquarters in Cambridge, Mass.

An internationally renowned expert in virology, immunology and vaccine development, Corey's research has focused on herpes viruses, HIV and other viral infections, particularly those associated with cancer. He also is principal investigator of the Hutchinson Center-based HIV Vaccine Trials Network, an international collaboration of scientists and institutions that combines clinical trials and laboratory-based studies to accelerate the development of HIV vaccines.

Corey is a professor of laboratory medicine and medicine, adjunct professor of pediatrics and microbiology, and holder of the Lawrence Corey Endowed Chair in Medical Virology at the University of Washington. He is also an infectious disease physician at Seattle Cancer Care Alliance.

Besides his leadership role, Corey is recognized as one of the most highly cited and funded investigators in the United States. He has authored 12 books and more than 600 scientific publications and is a member of numerous scientific committees and editorial boards.

His honors and awards include election in 2008 to the Institute of Medicine, a prestigious branch of the National Academy of Sciences. He is a fellow of the Infectious Diseases Society of America and is a member of the American Society for Clinical Investigation, the American Epidemiological Society and the Association of American Physicians.

In addition to Corey and Hartwell, other Academy members at the Hutchinson Center are Linda B. Buck, Ph.D., who in 2004 received the Nobel Prize in physiology or medicine for her groundbreaking work on the network responsible for our sense of smell; Mark T. Groudine, M.D., Ph.D., deputy director of the Hutchinson Center and former director of its Basic Sciences Division; Robert Eisenman, Ph.D., a leader in the field of oncogenes, aberrantly regulated genes that cause cancer; cell biologist Daniel Gottschling, Ph.D., a member of the Basic Sciences Division; and the late Harold M. Weintraub, Ph.D., an international leader in the field of molecular biology.

Since its founding in 1780, the Academy has elected leading "thinkers and doers" from each generation, including George Washington and Benjamin Franklin in the eighteenth century, Daniel Webster and Ralph Waldo Emerson in the nineteenth, and Albert Einstein and Winston Churchill in the twentieth. The current membership includes more than 250 Nobel laureates and more than 60 Pulitzer Prize winners.


'/>"/>

Contact: Dean Forbes
dforbes@fhcrc.org
206-667-2896
Fred Hutchinson Cancer Research Center
Source:Eurekalert

Related medicine news :

1. Hutchinson Center receives $10.24 million from NIH for Latina breast cancer research
2. Hutchinson Center and China CDC sign agreement for research and training collaboration
3. Fred Hutchinson Cancer Research Center scientist receives Presidential Early Career Award
4. NCI awards $11.5 million to Fred Hutchinson Cancer Research Center to lead breast cancer consortium
5. Fred Hutchinson Cancer Research Center to lead Immunotherapy Clinical Trials Network
6. Shanghai CDC and Hutchinson Center establish Shanghai Breast Health Resource Center
7. Hutchinson Center receives $8.2M to coordinate obesity and cancer consortium
8. Fred Hutchinson Cancer Research Center to co-lead 1 of 5 NCI-funded proteomics research centers
9. Hutchinson Center breaks ground for first collaborative cancer center in sub-Saharan Africa
10. Hutchinson Center scientists break through pancreas cancer treatment barrier
11. Hutchinson Center and TGen scientists discover potential break through in pancreatic cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... Washington, D.C. (PRWEB) , ... June 25, 2016 ... ... will discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June ... share their work on several important health care topics including advance care planning, ...
(Date:6/25/2016)... Miami, FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton ... Plant City Observer , brings up a new, often overlooked aspect of head lice: ... The closing for fumigation is not a common occurrence, but a necessary one in the ...
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding emergency ... its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. Ogunleye ... M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. Ogunleye ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as ... City area —Johnson is one of the first doctors to perform the treatment. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, ... the latter, setting the bar too high can result in disappointment, perhaps even self-loathing. ... toward their goal. , Research from PsychTests.com reveals that behind the ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... --  Pulmatrix, Inc ., (NASDAQ: PULM ), ... today that it was added to the Russell Microcap ... set of U.S. and global equity indexes on June ... for Pulmatrix," said Chief Executive Officer Robert Clarke ... in developing drugs for crucial unmet medical needs, and ...
(Date:6/23/2016)... June 23, 2016  MedSource announced today that ... e-clinical software solution of choice.  This latest decision ... value to their clients by offering a state-of-the-art ... relationship establishes nowEDC as the EDC platform of ... full-service clients.  "nowEDC has long been a preferred ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
Breaking Medicine Technology: